Compounds > vadimezan
Page last updated: 2024-09-03

vadimezan and gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate

vadimezan has been researched along with gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate in 1 studies

Compound Research Comparison

Studies
(vadimezan)		Trials
(vadimezan)		Recent Studies (post-2010)
(vadimezan)		Studies
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)		Trials
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)		Recent Studies (post-2010) (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)
2721610163831243

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bussink, J; Hectors, SJ; Hoeben, FJ; Jacobs, I; Janssen, HM; Keizer, HM; Lok, J; Nicolay, K; Peters, J; Schabel, MC; Strijkers, GJ1

Other Studies

1 other study(ies) available for vadimezan and gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate

ArticleYear
Improved Evaluation of Antivascular Cancer Therapy Using Constrained Tracer-Kinetic Modeling for Multiagent Dynamic Contrast-Enhanced MRI.
    Cancer research, 2018, 03-15, Volume: 78, Issue:6

    Topics: Animals; Capillary Permeability; Contrast Media; Dendrimers; Heterocyclic Compounds; Image Processing, Computer-Assisted; Kinetics; Magnetic Resonance Imaging; Mice, Inbred BALB C; Neoplasms, Experimental; Organometallic Compounds; Placebos; Xanthones

2018